中星集團控股(00055.HK)擬斥資1456.8萬港元購置機器進一步提升生產效率
格隆匯12月5日丨中星集團控股(00055.HK)發佈公告,2019年12月5日,公司全資附屬中大印刷(國際)有限公司作為買方與海德堡香港有限公司就購置平張紙膠印機訂立銷售合同,總合同價格168萬歐元(相當於約1456.8萬港元)。
公告表示,除集團現時於深圳的生產廠房外,集團現正在東莞市設置新生產廠房。於東莞的新生產廠房於成立後將由項目公司營運。為了配合集團的業務擴充計劃,公司管理層一直審視集團現有印刷產品製造機器的產能,並且認為集團應購置更多機器以進一步提升其生產效率。董事因此認為購置事項對集團而言屬有必要並且有利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.